Australia markets open in 1 hour 5 minutes
  • ALL ORDS

    7,142.20
    +57.10 (+0.81%)
     
  • AUD/USD

    0.6674
    -0.0047 (-0.69%)
     
  • ASX 200

    6,955.40
    +56.90 (+0.82%)
     
  • OIL

    69.50
    +1.86 (+2.68%)
     
  • GOLD

    1,943.60
    -39.20 (-1.98%)
     
  • Bitcoin AUD

    42,022.45
    -27.80 (-0.07%)
     
  • CMC Crypto 200

    612.63
    +7.58 (+1.25%)
     

Why Voyager Therapeutics Stock Is Sinking This Week

Why Voyager Therapeutics Stock Is Sinking This Week

Shares of the gene therapy company Voyager Therapeutics (NASDAQ: VYGR) were down by a little over 18% from their intraweek high as of 11:44 a.m. ET Friday, according to data provided by S&P Global Market Intelligence. Rather, Voyager's shares seem to be reverting to the mean following their enormous run-up earlier this month. As a refresher, the biotech's shares spiked by as much as 76% during the first two weeks of January as a result of the company's lucrative gene therapy deal with Neurocrine Biosciences (NASDAQ: NBIX).